Rafferty Asset Management Boosts Stake in Johnson & Johnson

Institutional investor increases holdings in pharmaceutical giant by 5% in third quarter

Mar. 3, 2026 at 7:55am

Got story updates? Submit your updates here. ›

Rafferty Asset Management LLC, an institutional investor, increased its stake in shares of Johnson & Johnson (NYSE: JNJ) by 5.0% in the third quarter, according to a recent 13F filing with the Securities and Exchange Commission. The firm now owns 268,564 shares of the company's stock, valued at $49.8 million as of the filing.

Why it matters

Johnson & Johnson is one of the world's largest and most diversified healthcare companies, with a portfolio spanning pharmaceuticals, medical devices, and consumer products. Institutional investors closely watch changes in ownership of major blue-chip stocks like JNJ, as it can signal broader market sentiment and investment trends.

The details

Rafferty Asset Management, an investment management firm, increased its position in Johnson & Johnson by purchasing an additional 12,710 shares during the third quarter. This brings the firm's total holdings in JNJ to 268,564 shares, representing a 5.0% increase from the previous quarter. Johnson & Johnson's stock has seen strong performance recently, reaching new all-time highs as the company continues to grow its pharmaceutical and medical device businesses.

  • Rafferty Asset Management increased its Johnson & Johnson holdings in the third quarter of 2026.

The players

Rafferty Asset Management LLC

An institutional investment management firm that increased its stake in Johnson & Johnson.

Johnson & Johnson

A multinational healthcare company that develops, manufactures, and markets pharmaceutical, medical device, and consumer products.

Got photos? Submit your photos here. ›

The takeaway

Rafferty Asset Management's increased stake in Johnson & Johnson reflects the continued investor confidence in the healthcare giant's diversified business model and growth prospects. As a bellwether stock, changes in institutional ownership of JNJ can provide insights into broader market trends and investor sentiment.